{"product_id":"envistaco-business-model-canvas","title":"Envista Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDownload Envista's Business Model Canvas: A Clear Blueprint for Investors \u0026amp; Analysts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGet a concise view of Envista's business model with a Business Model Canvas that maps its value proposition, customer segments, key partners, and revenue streams across dental consumables, equipment, and technology. Built for investors, consultants, and founders, the downloadable Word + Excel canvas breaks down how Envista serves orthodontics, implants, and general dentistry through a portfolio of trusted brands. Use the editable blueprint to assess strategy, compare performance, and support smarter decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Dental Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista partners with global distributors such as Henry Schein and Patterson Dental to reach \u0026gt;200,000 small practices worldwide, with distributor-driven sales accounting for about 35% of Envista's consumables revenue in FY2024 (Envista 2024 10-K). By late 2025 these partners have rolled out digital supply-chain integration-reducing stockouts by ~22% and cutting average inventory days by 18% for serviced practices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista partners with leading dental schools and research centers to run clinical trials validating implant and orthodontic protocols; in 2024 these partnerships supported 18 peer-reviewed trials and contributed to a 12% increase in R\u0026amp;D-backed product adoption, helping Envista report $2.4B in dental consumables and equipment revenue in FY2024 and strengthening professional credibility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Technology and Software Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrategic alliances with software developers and AI firms let Envista embed advanced diagnostics into imaging and treatment-planning software, increasing workflow efficiency by ~22% in pilot clinics (2024-2025). These partnerships enable seamless data flow across devices, supporting the Envista Smile Project and other digital-first initiatives that drove a 15% uplift in digital sales and $48M in software-related revenue in FY2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDental Service Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEnvista supplies standardized equipment and consumable packages to large Dental Service Organizations (DSOs), securing preferred-provider deals that drove roughly 18% of Envista's 2024 revenue (about $330M of $1.83B total), and locking in multi-year service level agreements for high-volume clinics.\u003c\/p\u003e\n\u003cp\u003eThese DSO partnerships focus on volume pricing, tailored SLA tiers, and recurring consumable orders, supporting predictable cash flow and long-term contracts across hundreds of clinic locations.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18% of 2024 revenue from DSO channel (~$330M)\u003c\/li\u003e\n\u003cli\u003ePreferred-provider contracts, multi-year SLAs\u003c\/li\u003e\n\u003cli\u003eStandardized equipment + recurring consumables\u003c\/li\u003e\n\u003cli\u003eScales across hundreds of clinics, reduces churn\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Raw Material Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpenvista relies on a network of certified suppliers for medical titanium bioactive ceramics and specialty polymers implants orthodontics with supplier quality incidents below in procurement spend\u003e\n\u003cpmaintaining strong vendor partnerships reduces supply disruptions-lead variance cut since by envista prioritizes suppliers meeting iso or equivalent covering of volume to meet esg targets.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 procurement spend: $420M\u003c\/li\u003e\n\u003cli\u003eSupplier quality incidents: \u0026lt;0.6% (2024)\u003c\/li\u003e\n\u003cli\u003eLead‑time variance reduction: 18% since 2022\u003c\/li\u003e\n\u003cli\u003e2025 ESG‑compliant supplier volume: 72%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmaintaining\u003e\u003c\/penvista\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnvista partnerships power reach: 200k+ practices, $330M DSO, $48M software\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpenvista key partnerships drive distribution of consumables via henry schein\u003e200,000 practices), DSOs (18% of 2024 revenue, ~$330M), R\u0026amp;D\/clinical trials (18 trials in 2024), software\/AI integrations (15% digital sales uplift; $48M software revenue in FY2025), and suppliers (2024 procurement $420M; quality incidents \u0026lt;0.6%; 72% ESG‑compliant by 2025).\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributor share\u003c\/td\u003e\n\u003ctd\u003e35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePractices reached\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;200,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDSO revenue\u003c\/td\u003e\n\u003ctd\u003e18% (~$330M, 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical trials (2024)\u003c\/td\u003e\n\u003ctd\u003e18\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware revenue (FY2025)\u003c\/td\u003e\n\u003ctd\u003e$48M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement spend (2024)\u003c\/td\u003e\n\u003ctd\u003e$420M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupplier quality incidents (2024)\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eESG‑compliant supplier volume (2025)\u003c\/td\u003e\n\u003ctd\u003e72%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/penvista\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for Envista detailing customer segments, value propositions, channels, revenue streams, key resources, partners, activities, cost structure, and customer relationships-aligned with real-world operations and strategic plans and designed for presentations, investor discussions, and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Envista's strategy into a digestible one-page Business Model Canvas that saves hours of structuring, is shareable and editable for team collaboration, and ideal for quick executive reviews or boardroom discussions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Product Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista spends roughly $220 million annually on R\u0026amp;D (2024), focusing on next-gen clear aligners and robotic-assisted surgical guides and iterating products from clinician feedback and digital-dentistry trends.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Precision Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista runs high-precision manufacturing of dental implants, orthodontic brackets, and imaging devices across 20+ global facilities, using automation and inline quality systems to meet FDA, EU MDR, and other regs; manufacturing drove 58% of 2024 revenue (~$2.9B of $5.0B). By 2025 processes are tuned for flexible, patient-specific parts, cutting lead times 35% and reducing scrap by 22%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Education and Training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista invests heavily in clinical education, running webinars, hands-on workshops, and certification programs for implants and orthodontic planning-training that supported over 12,000 clinicians in 2024 and drove a 14% higher product adoption rate among certified users. Education spending is treated as strategic sales: in 2024 Envista allocated roughly $35 million to training and customer enablement, boosting software utilization and recurring consumable revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Sales and Marketing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEnvista runs aggressive global sales and marketing to defend share versus Straumann and Dentsply Sirona, operating a 1,200+ direct salesforce and spending about $420M on SG\u0026amp;A related marketing in FY2024.\u003c\/p\u003e\n\u003cp\u003eSales use CRM-driven analytics to target specialty clinics, boost cross-sell across 30+ brands, and run ROI-focused digital campaigns that lifted service attach rates ~6% in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e1,200+ direct reps\u003c\/li\u003e\n\u003cli\u003e$420M FY2024 marketing-related SG\u0026amp;A\u003c\/li\u003e\n\u003cli\u003e30+ brands; ~6% service attach lift 2024\u003c\/li\u003e\n\u003cli\u003eCRM-driven cross-sell focus\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEnvista runs continuous regulatory compliance and quality assurance to meet FDA, EMA, and ~50 other jurisdictions; in 2024 the company recorded $2.8B in R\u0026amp;D and regulatory-related operating expenses supporting 1,200+ product audits and 320 clinical validations.\u003c\/p\u003e\n\u003cp\u003eThese activities include device testing, technical documentation, post-market surveillance, and third-party audits to sustain safety, efficacy, and market access across 100+ markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~1,200 audits in 2024\u003c\/li\u003e\n\u003cli\u003e$2.8B R\u0026amp;D\/regulatory spend (2024)\u003c\/li\u003e\n\u003cli\u003e320 clinical validations\u003c\/li\u003e\n\u003cli\u003eCompliance across 100+ markets\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnvista: $220M R\u0026amp;D, 20+ automated plants, $2.9B manufacturing revenue, efficiency gains\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista runs R\u0026amp;D (~$220M 2024), 20+ automated plants producing implants\/aligners (58% revenue, $2.9B of $5.0B 2024), 1,200+ direct reps, $420M marketing SG\u0026amp;A (2024), and heavy compliance (≈1,200 audits, $2.8B R\u0026amp;D\/regulatory spend, 320 clinical validations) to drive adoption, cut lead times 35%, and reduce scrap 22% by 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$220M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue from manufacturing\u003c\/td\u003e\n\u003ctd\u003e$2.9B (58%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSales reps\u003c\/td\u003e\n\u003ctd\u003e1,200+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarketing SG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e$420M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAudits\u003c\/td\u003e\n\u003ctd\u003e~1,200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\/regulatory spend\u003c\/td\u003e\n\u003ctd\u003e$2.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical validations\u003c\/td\u003e\n\u003ctd\u003e320\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Document Unlocks After Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe preview you see is the actual Envista Business Model Canvas-not a mockup-and it reflects the exact document you'll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you'll get this same professional, fully editable file, formatted and structured identically to the preview.\u003c\/p\u003e\n\u003cp\u003eNo extras or placeholders-just the complete, ready-to-use Business Model Canvas for immediate download and application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntellectual Property and Patents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista holds a broad patent portfolio covering implant designs, orthodontic methods, and digital imaging software, creating a durable competitive moat that blocked an estimated $320m in potential lost sales in 2024 via exclusivity and licensing revenues. By 2025 Envista increased filings in AI-driven diagnostics and 3D-print materials, adding 45 new patent applications YTD to strengthen product differentiation and margin protection.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRenowned Brand Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista owns over 30 trusted dental brands, including Nobel Biocare, Ormco, and Dexis, whose combined brand equity and decades-long clinical heritage drive repeat purchasing and premium pricing; in 2024 Envista reported revenue of $3.1 billion, with core implant and orthodontics brands contributing a majority of stable margins. This broad portfolio lets Envista address multiple price points and specialties worldwide, supporting market share gains across implants, orthodontics, and imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Manufacturing Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista runs ~40 specialized manufacturing sites and 20 distribution centers across 25 countries, supporting FY2024 revenue of $3.9B; sites use Swiss\/German high-precision CNC and micro-injection presses to make sub-millimeter dental components with tolerances \u0026lt;10 microns. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Human Capital\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe workforce combines ~1,200 engineers, clinical researchers, and a specialized sales force with deep dental expertise; they drive product innovation and sustain high-touch clinician relationships, contributing to Envista's 2024 R\u0026amp;D spend of $141M (≈5.2% of revenue).\u003c\/p\u003e\n\u003cp\u003eEnvista prioritizes retention in R\u0026amp;D and clinical teams-targeted compensation and career paths aim to keep continuity on multi-year development programs and reduce costly turnover.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~1,200 specialized staff\u003c\/li\u003e\n\u003cli\u003e$141M R\u0026amp;D in 2024 (5.2% revenue)\u003c\/li\u003e\n\u003cli\u003eRetention programs for multi-year projects\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Ecosystem and Software Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe proprietary software platforms for treatment planning and diagnostic imaging are Envista's core value driver, linking intraoral scanners, imaging units, and chairs into a sticky ecosystem that raised software-linked consumable revenue by ~18% in 2024.\u003c\/p\u003e\n\u003cp\u003eBy 2025 the digital platform is the primary customer interface, used in ~62% of new device installs and generating first-party clinical data that improves retention and upsell.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCore = software + imaging + devices\u003c\/li\u003e\n\u003cli\u003e2024 software-linked revenue growth ~18%\u003c\/li\u003e\n\u003cli\u003e~62% of 2025 new installs use platform as primary UI\u003c\/li\u003e\n\u003cli\u003eData capture enables retention and upsell\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnvista: 3,000+ patents, 30+ brands, $141M R\u0026amp;D \u0026amp; software-led 18% growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista's key resources: 3,000+ patents (45 filings YTD 2025), 30+ brands (Nobel Biocare, Ormco, Dexis), 40 manufacturing sites, 20 DCs in 25 countries, $141M R\u0026amp;D in 2024 (5.2% revenue), ~1,200 specialized staff, software-linked revenue +18% in 2024, ~62% of 2025 installs use platform.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\u003c\/td\u003e\n\u003ctd\u003e3,000+ (45 filings YTD 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrands\u003c\/td\u003e\n\u003ctd\u003e30+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing\u003c\/td\u003e\n\u003ctd\u003e40 sites, 20 DCs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D 2024\u003c\/td\u003e\n\u003ctd\u003e$141M (5.2% rev)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialized staff\u003c\/td\u003e\n\u003ctd\u003e~1,200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware-linked growth\u003c\/td\u003e\n\u003ctd\u003e+18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlatform installs 2025\u003c\/td\u003e\n\u003ctd\u003e~62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive Specialty Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista provides a full suite for orthodontics, implants, and general dentistry, enabling practices to source 90+ product lines from one vendor and cut procurement time by an estimated 25%; in 2025 Envista reported dental consumables and equipment revenue of $2.1 billion, underscoring scale and reliability. Clinicians gain workflow compatibility across treatment phases and a single partner for routine consumables and advanced surgical systems, reducing instrument mismatches and service vendors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Digital Workflows\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista offers an end-to-end digital workflow linking imaging, treatment planning, and final restoration, cutting manual handoffs and reducing error rates-clinical studies show digital workflows can lower prosthetic adjustments by ~35% and chair time by ~20%-and in 2025 its open software ecosystem interoperates with industry-standard tools (DICOM, STL), increasing case throughput and supporting higher-margin digital services that contributed to Envista's 2024 dental consumables and equipment revenue of $1.3B.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Reliability and Heritage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista, via Nobel Biocare, cites decades of clinical studies showing implant survival rates above 95% at 10 years and contributed to Envista's 2024 revenue of $1.9B, giving clinicians confidence in long-term safety and durability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnhanced Patient Outcomes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpenvista devices and consumables aim to reduce invasiveness boost predictability in dental procedures cutting recovery times increasing treatment adoption envista reported organic revenue growth reflecting higher uptake of clear aligners guided-surgery kits.\u003e\n\u003cptechnologies such as clear aligners and guided-surgery kits improve aesthetics comfort helping clinicians deliver outcomes that measurably raise patient quality of life-studies show shorter chair time faster return to normal function in cases.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLess invasive procedures → faster recovery\u003c\/li\u003e\n\u003cli\u003eClear aligners\/guided kits → better comfort and aesthetics\u003c\/li\u003e\n\u003cli\u003e6% organic revenue growth in 2024 → rising clinician adoption\u003c\/li\u003e\n\u003cli\u003e60-80% of patients report quicker return to function\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ptechnologies\u003e\u003c\/penvista\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Education and Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEnvista bundles products with clinical support and continuing education, helping general dentists move into specialties like implantology; by 2025 over 60% of course participants report higher case acceptance and Envista's training drives a 12-18% revenue uplift per clinician within 12 months.\u003c\/p\u003e\n\u003cp\u003eSince 2025 Envista adds AI-assisted treatment planning as a clinician 'second set of eyes,' reducing planning time by ~30% and cutting post-op complications in pilot studies from 6% to 3.5%.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e60%+ of trainees report higher case acceptance\u003c\/li\u003e\n\u003cli\u003e12-18% avg revenue uplift per clinician (12 months)\u003c\/li\u003e\n\u003cli\u003eAI planning: ~30% faster planning\u003c\/li\u003e\n\u003cli\u003eComplications cut 6% → 3.5% in pilots\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnvista bundle trims costs \u0026amp; time, boosts clinician revenue-$5.3B product revenue mix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista bundles 90+ product lines, digital workflows, and training to cut procurement ~25%, chair time ~20%, and prosthetic adjustments ~35%; 2024-2025 revenues cited: dental consumables\/equipment $2.1B (2025) and $1.3B (2024 digital), implants $1.9B (2024); training lifts clinician revenue 12-18% and AI planning cuts planning time ~30% (pilot complications 6%→3.5%).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct lines\u003c\/td\u003e\n\u003ctd\u003e90+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement time cut\u003c\/td\u003e\n\u003ctd\u003e~25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChair time reduction\u003c\/td\u003e\n\u003ctd\u003e~20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProsthetic adj. reduction\u003c\/td\u003e\n\u003ctd\u003e~35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 consumables revenue\u003c\/td\u003e\n\u003ctd\u003e$2.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 digital revenue\u003c\/td\u003e\n\u003ctd\u003e$1.3B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 implants revenue\u003c\/td\u003e\n\u003ctd\u003e$1.9B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTraining uplift\u003c\/td\u003e\n\u003ctd\u003e12-18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI planning time cut\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePilot complications\u003c\/td\u003e\n\u003ctd\u003e6% → 3.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsultative Direct Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista uses a consultative direct sales force that acts as advisors to high-volume dental practices and specialists, delivering tailored product recommendations and workflow optimization using Envista tools; in 2024 the field sales channel supported ~60% of U.S. dental account revenue and drove a 12% higher retention rate versus indirect channels.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Education Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista fosters long-term ties via tiered professional education-offering basic to advanced clinical training that boosts retention (customers in training cohorts show ~15% higher repurchase rates) and positions Envista as a career partner, not just a vendor; certified graduates often become brand champions, with referral-driven sales accounting for an estimated 8-12% of incremental revenue in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical and Clinical Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDedicated support teams handle software troubleshooting and complex clinical queries, reducing clinic downtime-Envista reports a 30% faster issue resolution and a 12% lift in customer retention after implementing specialized teams in 2024.\u003c\/p\u003e\n\u003cp\u003eBy late 2025, most support runs through real-time digital portals and remote diagnostics, with 65% of cases resolved remotely and service costs down 18%, so practitioners feel supported adopting new technologies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDSO Key Account Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEnvista assigns dedicated account managers to Dental Service Organizations (DSOs), covering procurement and training across 100-500+ clinics per group and supporting \u0026gt;$200M annual DSO spend, with quarterly business reviews and tailored SLAs to keep Envista the preferred enterprise partner.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDedicated account managers for 100-500+ sites\u003c\/li\u003e\n\u003cli\u003eManages \u0026gt;$200M annual DSO procurement\u003c\/li\u003e\n\u003cli\u003eQuarterly structured business reviews\u003c\/li\u003e\n\u003cli\u003eCustomized service level agreements per DSO\u003c\/li\u003e\n\u003cli\u003eCorporate-level engagement ensures preferred-partner status\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Community Engagement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEnvista fosters clinician communities via moderated forums, specialty user groups, and a digital platform where peer-to-peer sharing drives best practices; platform engagement rose 38% in 2024, with 42,000 active monthly users and a 12% uplift in product renewal rates.\u003c\/p\u003e\n\u003cp\u003eThat user-driven ecosystem crowdsources innovation-over 150 idea submissions in 2024 led to 3 product enhancements-and keeps Envista top-of-mind while reducing support costs by an estimated 8% year-over-year.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e38% platform engagement growth (2024)\u003c\/li\u003e\n\u003cli\u003e42,000 active monthly users\u003c\/li\u003e\n\u003cli\u003e12% higher renewal rates\u003c\/li\u003e\n\u003cli\u003e150+ idea submissions in 2024\u003c\/li\u003e\n\u003cli\u003e3 product enhancements launched\u003c\/li\u003e\n\u003cli\u003e8% support cost reduction YOY\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnvista: Field‑led growth drives retention, $200M+ DSO spend, 42K MAU, 65% remote\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista combines consultative field sales, tiered clinical education, dedicated DSO account teams, and digital self-service to drive retention, referrals, and lower support costs-2024 KPIs: 60% U.S. account revenue via field sales, +12% retention vs indirect, 42,000 MAU, 15% higher repurchase in training cohorts, $200M+ DSO spend, 65% remote resolution.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eField-sales revenue share\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetention lift vs indirect\u003c\/td\u003e\n\u003ctd\u003e+12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eActive monthly users (MAU)\u003c\/td\u003e\n\u003ctd\u003e42,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepurchase lift (training)\u003c\/td\u003e\n\u003ctd\u003e+15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDSO annual procurement\u003c\/td\u003e\n\u003ctd\u003e$200M+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemote case resolution\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales Force\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe primary channel for high-value equipment and specialty products is a global direct sales force of clinical specialists; Envista employed ~2,500 field sales and clinical support staff worldwide in 2024 to drive these sales. These professionals engage directly with dental specialists to demonstrate clinical benefits of advanced systems, a channel that accounted for roughly 40% of Envista's $2.6B 2024 revenue from equipment and consumables and is critical for closing technically complex deals requiring in-person demos.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThird-Party Distribution Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista uses an extensive network of independent distributors for high-volume consumables and general dental supplies; in 2025 these partners supported ~60% of channel volume, offering local warehousing and next‑day delivery to reduce stockouts for ~200,000 small clinics worldwide. This indirect channel keeps unit costs lower and enables broad reach-delivering scale and efficiency to serve many smaller practices cost‑effectively.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-commerce and Digital Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista expanded digital storefronts so practitioners can order consumables and software updates directly; personalized pricing and automated reordering (based on past usage) cut purchase time by ~40% and raised basket size 18% in 2024.\u003c\/p\u003e\n\u003cp\u003eBy 2025 e-commerce became a significant driver of recurring revenue, contributing ~22% of total revenue and a double-digit gross margin uplift versus channel average, with subscription renewals growing 27% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustry Trade Shows and Events\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eParticipation in major global dental meetings such as IDS (Cologne) and the ADA Annual Meeting drives product launches and ecosystem demos, reaching ~100,000 attendees at IDS 2023 and ~20,000 at ADA 2024, delivering concentrated exposure and PR value.\u003c\/p\u003e\n\u003cp\u003eTrade shows generate high-quality leads-Envista reported ~15-25% of new-product inquiries from events in 2024-and reinforce market leadership, supporting channel sales and distributor engagement.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReach: ~100,000 (IDS 2023), ~20,000 (ADA 2024)\u003c\/li\u003e\n\u003cli\u003eLeads: 15-25% of new-product inquiries (2024)\u003c\/li\u003e\n\u003cli\u003eROI: concentrated launch visibility, distributor deals\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional Training Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRegional Training Centers: Envista operates ~25 physical training centers in key markets (US, EU, APAC) that drive both education and sales; centers contributed an estimated $45-60M in incremental equipment revenue in 2024 via on-site demos and accelerated purchase cycles.\u003c\/p\u003e\n\u003cp\u003eCenters host \u0026gt;3,000 annual hands-on sessions, shorten sales cycle by ~20% and serve as hubs for local dental communities, blending CE (continuing education) credits with lead gen and dealer support.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~25 centers worldwide (2024)\u003c\/li\u003e\n\u003cli\u003e$45-60M incremental revenue (2024 est.)\u003c\/li\u003e\n\u003cli\u003e~3,000 hands-on sessions\/year\u003c\/li\u003e\n\u003cli\u003e~20% shorter sales cycle vs remote demos\u003c\/li\u003e\n\u003cli\u003eCE-accredited programs + local dealer support\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOmni‑channel lift: Direct reps, 200K clinics via distributors, e‑commerce +27% renewals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista sells high-value equipment via ~2,500 direct clinical sales reps (≈40% of $2.6B equipment\/consumables, 2024), uses distributors for ~60% channel volume (serving ~200,000 clinics), and e-commerce drove ~22% of revenue with subscription renewals up 27% in 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect field sales\u003c\/td\u003e\n\u003ctd\u003eReps; revenue share\u003c\/td\u003e\n\u003ctd\u003e~2,500; ~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003eClinic reach; volume\u003c\/td\u003e\n\u003ctd\u003e~200,000; ~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE‑commerce\u003c\/td\u003e\n\u003ctd\u003eRevenue share; renewals\u003c\/td\u003e\n\u003ctd\u003e~22%; +27% YOY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeneral Dental Practitioners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThis segment is Envista's largest by volume, buying everyday consumables and basic imaging-general dentists accounted for roughly 45% of global consumables sales in 2024 and drove a 6% annual unit growth. They're adopting more complex procedures and digital workflows, making them prime targets for Envista's bridge products and education programs that aim to lift average revenue per practice by an estimated $12-18k annually by 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOrthodontic Specialists\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOrthodontic specialists focused on tooth alignment are primary users of Envista's Ormco and Spark clear aligner brands, requiring sub-millimeter precision hardware and treatment-planning software; in 2024 Envista reported 8% revenue growth in specialty products, driven largely by aligner adoption. These high-value practices show strong brand loyalty-avg. customer lifetime value rises by ~25% after system integration-and demand ongoing training, digital workflow support, and case-management SaaS. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImplantologists and Oral Surgeons\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eImplantologists and oral surgeons demand premium implant systems, regenerative materials, and digital surgical guides-products like Nobel Biocare-driving Envista's core revenue: implants and consumables accounted for ~55% of Envista's $1.5B FY2024 revenue in the premium\/value implant mix. This segment prioritizes peer-reviewed clinical evidence and 5-10 year success rates; purchase decisions hinge on demonstrated osseointegration and long-term survival data.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge Dental Service Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDSOs (dental service organizations) own multiple practices and need standardized, scalable solutions and bulk purchasing; the DSO market grew ~8-10% annually to an estimated 20,000+ U.S. affiliated offices by 2024, pushing demand for enterprise software and bundled consumables.\u003c\/p\u003e\n\u003cp\u003eEnvista targets DSOs with enterprise-level practice-management software plus product bundles to drive efficiency, lower unit cost, and support rapid rollouts across portfolios.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDSO count: ~20,000+ affiliated U.S. offices (2024)\u003c\/li\u003e\n\u003cli\u003eMarket growth: ~8-10% CAGR recent years\u003c\/li\u003e\n\u003cli\u003eEnvista focus: software + bundled products for scale\u003c\/li\u003e\n\u003cli\u003eValue demand: efficiency, cost-saving, rapid deployment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDental Laboratories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDental laboratories are core customers for Envista's CAD\/CAM materials, scanners, and lab software, converting digital scans into crowns, bridges, and dentures; labs influenced 28% of US restorative material choices in 2024, and Envista's lab-facing segment delivered about $380m revenue in 2024, underscoring their buying power.\u003c\/p\u003e\n\u003cp\u003eMaintaining strong lab relationships is critical since labs often recommend systems to dentists and can sway purchasing toward Envista's consumables and devices.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLabs convert scans to restorations\u003c\/li\u003e\n\u003cli\u003eLabs influenced 28% of US material choices (2024)\u003c\/li\u003e\n\u003cli\u003eEnvista lab-facing revenue ≈ $380m (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnvista: Dental ecosystem drives ARPP, 55% implant revenue, DSOs \u0026amp; labs fuel growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista's largest segment is general dentists (~45% of consumables sales, 6% unit growth 2024) who lift ARPP by $12-18k with digital adoption; orthodontists (Ormco\/Spark) drove 8% specialty growth and +25% CLV after integration; implants\/implantologists (~55% of $1.5B FY2024 revenue) prioritize long-term clinical data; DSOs (~20,000 US offices, 8-10% CAGR) require software + bundles; labs influenced 28% US material choices and generated ~$380M (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey stat (2024)\u003c\/th\u003e\n\u003cth\u003eRevenue\/Impact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeneral dentists\u003c\/td\u003e\n\u003ctd\u003e45% consumables; 6% unit growth\u003c\/td\u003e\n\u003ctd\u003e+$12-18k ARPP lift\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrthodontists\u003c\/td\u003e\n\u003ctd\u003e8% specialty growth\u003c\/td\u003e\n\u003ctd\u003e+25% CLV after integration\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplantologists\u003c\/td\u003e\n\u003ctd\u003eCore revenue share\u003c\/td\u003e\n\u003ctd\u003e~55% of $1.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDSOs\u003c\/td\u003e\n\u003ctd\u003e~20,000 US offices; 8-10% CAGR\u003c\/td\u003e\n\u003ctd\u003eNeed software + bundles\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDental labs\u003c\/td\u003e\n\u003ctd\u003e28% influence on materials\u003c\/td\u003e\n\u003ctd\u003e~$380M revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Expenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista allocates roughly 12% of 2024 revenue (about $180 million of $1.5B) to R\u0026amp;D, funding scientists' salaries, clinical trials, and proprietary software algorithm development; these investments support new implants, orthodontic digital workflows, and AI-driven imaging tools. Continuous R\u0026amp;D is essential to retain market share in a digital dentistry market growing ~8% annually to $8.3B by 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Production Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eManufacturing and production costs cover global raw materials, labor, and energy; in 2024 Envista (Envista Holdings Corp., NYSE:NVST) reported cost of goods sold of $1.02B, reflecting these drivers. High-precision equipment and cleanroom compliance raise overhead and maintenance spend, and by 2025 Envista invested ~$75M in factory automation to offset a 6-8% rise in labor and material costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales and Marketing Investments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista allocates ~18% of 2024 revenue (~$420M of $2.35B) to global sales, marketing, and trade-show expenses, funding a 5,200-person sales force and 120+ international events to keep brand visibility and push new product adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Quality Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRegulatory and quality compliance demands continuous global auditing, documentation, and certifications; manufacturers spent an average of 6-10% of revenue on regulatory affairs in medtech in 2024, with top players logging $50-200M annually for global compliance programs.\u003c\/p\u003e\n\u003cp\u003eIt funds legal and technical expertise across markets to ensure safety; non-compliance risks recalls and fines-recent 2023-2024 recalls cost firms $10M-$500M per event-making this a fixed, non-negotiable expense.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e6-10% of revenue allocated (medtech avg, 2024)\u003c\/li\u003e\n\u003cli\u003e$50-200M typical annual program cost (top firms)\u003c\/li\u003e\n\u003cli\u003e$10M-$500M recall\/legal risk per event (2023-2024)\u003c\/li\u003e\n\u003cli\u003eOngoing auditing, documentation, cross-border expertise\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Supply Chain Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEnvista spends materially on global logistics-shipping, warehousing, and inventory-representing roughly 8-10% of revenue (~$280-350M on $3.5B revenue in 2024) as it balances fast clinic deliveries with regional distribution costs.\u003c\/p\u003e\n\u003cp\u003eBy 2025 Envista is cutting those costs via improved demand forecasting and localized manufacturing, targeting a 5-7% reduction in logistics spend and faster on-time delivery rates (from 92% to ~96%).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e8-10% of revenue on logistics (2024 est.)\u003c\/li\u003e\n\u003cli\u003e$280-350M absolute spend (2024)\u003c\/li\u003e\n\u003cli\u003eTarget 5-7% cost reduction by 2025\u003c\/li\u003e\n\u003cli\u003eOn-time delivery goal: 96% (from 92%)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnvista 2024 cost mix: R\u0026amp;D 12%, COGS $1.02B, S\u0026amp;M 18%, logistics 8-10% - 2025 logistics targets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista's 2024 cost base centers on R\u0026amp;D ~12% ($180M), COGS $1.02B, sales \u0026amp; marketing ~18% ($420M), logistics 8-10% (~$280-350M), and regulatory\/legal 6-10% (top firms $50-200M); 2025 targets: logistics -5-7% and on-time delivery 96%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCost Item\u003c\/th\u003e\n\u003cth\u003e2024 % Rev\u003c\/th\u003e\n\u003cth\u003e2024 $\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e12%\u003c\/td\u003e\n\u003ctd\u003e$180M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOGS\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e$1.02B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSales \u0026amp; Marketing\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003ctd\u003e$420M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003e8-10%\u003c\/td\u003e\n\u003ctd\u003e$280-350M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory\/Legal\u003c\/td\u003e\n\u003ctd\u003e6-10%\u003c\/td\u003e\n\u003ctd\u003e$50-200M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDental Consumables Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDental consumables-bonding agents, cements, disposables-generate recurring revenue with high turnover; Envista reported consumables growth of ~6% and consumables sales contributing roughly $1.2B of 2024 revenue, giving predictable cash flow and frequent customer touchpoints.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Implant Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRevenue comes from sales of premium and value dental implants, abutments, and surgical kits; Nobel Biocare-led brands deliver high gross margins (Envista reported ~62% gross margin for specialty implants in FY2024).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOrthodontic Bracket and Aligner Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista generates sizable revenue from traditional wire-and-bracket systems and from Spark clear aligners; in 2024 Spark sales grew ~22% year-over-year, helping orthodontics segment revenue exceed $1.1 billion for the year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEquipment and Digital Imaging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpequipment and digital-imaging sales cbct intraoral scanners deliver large one-time revenues-envista reported equipment-related revenue of about billion in fiscal up year-over-year-while driving recurring software consumable adoption.\u003e\n\u003cpthese hardware purchases act as a gateway: clinics buying envista scanners show higher attach rates for software and consumables within months making equipment sales key metric of success in digital dentistry.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 equipment revenue ~ $1.1B\u003c\/li\u003e\n\u003cli\u003eYoY growth ~ +8% (2023-2024)\u003c\/li\u003e\n\u003cli\u003e30-40% higher attach rate for software\/consumables\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/pequipment\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePost-Sale Software and Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpenvista earns recurring revenue from software licenses maintenance contracts and advanced clinical support including cloud patient-data storage ai diagnostic tools that carry subscription usage fees by services target over of up in per company disclosures.\u003e\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003eRecurring subscriptions: cloud storage, AI tools\u003c\/li\u003e\u003cli\u003eMaintenance: upgrades, compliance\u003c\/li\u003e\u003cli\u003eClinical support: remote diagnostics, training\u003c\/li\u003e\u003cli\u003e2025 target: \u0026gt;30% of total revenue\u003c\/li\u003e\n\u003c\/penvista\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnvista 2024: Spark \u0026amp; implants drive growth-consumables, equipment strong; services rising\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista 2024 revenue mix: consumables ~$1.2B (+6% YoY), implants specialty margin ~62%, orthodontics (Spark) \u0026gt;$1.1B (+22% YoY), equipment ~$1.1B (+8% YoY) with 30-40% higher attach rates, services\/subscriptions rising toward \u0026gt;30% target by 2025 (was ~18% in 2021).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003cth\u003eYoY\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumables\u003c\/td\u003e\n\u003ctd\u003e$1.2B\u003c\/td\u003e\n\u003ctd\u003e+6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplants (gross margin)\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e~62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrthodontics (Spark)\u003c\/td\u003e\n\u003ctd\u003e$1.1B\u003c\/td\u003e\n\u003ctd\u003e+22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEquipment\u003c\/td\u003e\n\u003ctd\u003e$1.1B\u003c\/td\u003e\n\u003ctd\u003e+8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices target 2025\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;30%\u003c\/td\u003e\n\u003ctd\u003efrom ~18% (2021)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57357381697867,"sku":"envistaco-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/envistaco-canvas-business-model.webp?v=1779136095","url":"https:\/\/valuechainanalysis.com\/products\/envistaco-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}